V. Taly is a CNRS research director and group leader of the Translational Research And Microfluidics group within the MEPPOT team (Personalized medicine, pharmacogenomics and therapeutic optimization). She is deputy director of this team headed by Prof. P. Laurent-Puig in the Cordeliers Research Center (CRC). Her group performs interdisciplinary researches aiming at developing and validating microfluidic tools for cancer research in close collaboration with clinicians and researchers in oncology and toxicology. Since 2008, she developed droplet-based digital procedures for Cancer diagnosis. Recently, her research has been dedicated to the clinical validation of droplet-based microfluidics for the non-invasive detection of Cancer biomarkers, the highlighting of new Cancer Biomarkers and the development of original tools and procedures for their detection with applications in personalized medicine, cancer recurrence detection and cancer diagnostics.
November 7 2019, 08:30
Keynote Address: Use Of Digital PCR For Cancer Patient Follow-Up
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.